Neurotrophic factors: past and future.
Moonen
G
G
Department of Neurology, University of Liege, Belgium.
Malgrange
B
B
Rigo
J M
JM
Rogister
B
B
D000818:Animals; D019208:Brain-Derived Neurotrophic Factor / Q000502:physiology; D020934:Ciliary Neurotrophic Factor; D005346:Fibroblast Growth Factors / Q000502:physiology; D051100:Glial Cell Line-Derived Neurotrophic Factor; D006801:Humans; D051379:Mice; D018345:Mice, Knockout; D009414:Nerve Growth Factors / Q000502:physiology* / Q000627:therapeutic use; D009419:Nerve Tissue Proteins / Q000502:physiology; D009422:Nervous System Diseases / Q000628:therapy; D011518:Proto-Oncogene Proteins / Q000502:physiology; D020794:Receptor Protein-Tyrosine Kinases / Q000502:physiology; D020917:Receptor, trkA; D017475:Receptors, Nerve Growth Factor / Q000502:physiology; D016212:Transforming Growth Factor beta / Q000502:physiology
D019208:Brain-Derived Neurotrophic Factor; D020934:Ciliary Neurotrophic Factor; C495039:GDNF protein, human; C495040:Gdnf protein, mouse; D051100:Glial Cell Line-Derived Neurotrophic Factor; D009414:Nerve Growth Factors; D009419:Nerve Tissue Proteins; D011518:Proto-Oncogene Proteins; D017475:Receptors, Nerve Growth Factor; D016212:Transforming Growth Factor beta; D005346:Fibroblast Growth Factors; D020794:Receptor Protein-Tyrosine Kinases; D020917:Receptor, trkA